Introduction and objectives The UK has for some time had the facility to use tibilone, an HRT agent, in the management of women who complain of low sexual desire. There have been at least 2 pharmaceutical companies who have conducted surveys among health care workers in regard of attitudes to patient management in women with low desire- in those pre and post menopausal. Results Summaries of the above will be presented
Conflict of Interest: Educational Grant For Travel Is Possible-But None Confirmed So Far
Financial Support/Funding: None disclosed
Sydney, Australia, April 2007
more about this speaker
